<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33557211</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Chronic Intermittent Mild Whole-Body Hypothermia Is Therapeutic in a Mouse Model of ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">320</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10020320</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes motor neuron degeneration. There are no cures or effective treatments for ALS. Therapeutic hypothermia is effectively used clinically to mitigate mortality in patients with acute acquired brain injury and in surgical settings to minimize secondary brain injury. The efficacy of therapeutic hypothermia in chronic neurodegenerative disorders has not been examined. We tested the hypothesis that mild hypothermia/cold acclimation is therapeutic in a transgenic mouse model of ALS caused by expression of mutated human <i>superoxide dismutase-1</i> gene. At presymptomatic stages of disease, body temperatures (oral and axial) of mutant male mice were persistently hyperthermic (38-38.5 &#xb0;C) compared to littermate controls, but at end-stage disease mice were generally hypothermic (36-36.5 &#xb0;C). Presymptomatic mutant mice (awake-freely moving) were acclimated to systemic mild hypothermia using an environmentally controlled chamber (12 h-on/12-off or 24 h-on/24 h-off) to lower body temperature (1-3 &#xb0;C). Cooled ALS mice showed a significant delay in disease onset (103-112 days) compared to normothermia mice (80-90 days) and exhibited significant attenuation of functional decline in motor performance. Cooled mice examined at 80 days had reduced motor neuron loss, mitochondrial swelling, and spinal cord inflammation compared to non-cooled mice. Cooling attenuated the loss of heat-shock protein 70, mitochondrial uncoupling protein-3, and sumoylated-1 (SUMO1)-conjugated proteins in skeletal muscle and disengaged the mitochondrial permeability transition pore. Cooled ALS mice had a significant extension of lifespan (148 &#xb1; 7 days) compared to normothermic mice (135 &#xb1; 4 days). Thus, intermittent systemic mild hypothermia is therapeutic in mouse ALS with protective effects manifested within the CNS and skeletal muscle that target mitochondria.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Lee J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Departments of Pathology, Division of Neuropathology, Neuroscience, and Anesthesiology and Critical Medicine and the Pathobiology Graduate Training Program, Johns Hopkins University School of Medicine, 558 Ross Building, 720 Rutland Avenue, Baltimore, MD 21205-2196, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niedzwiecki</LastName><ForeName>Mark V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Departments of Pathology, Division of Neuropathology, Neuroscience, and Anesthesiology and Critical Medicine and the Pathobiology Graduate Training Program, Johns Hopkins University School of Medicine, 558 Ross Building, 720 Rutland Avenue, Baltimore, MD 21205-2196, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Pathology, Division of Neuropathology, Neuroscience, and Anesthesiology and Critical Medicine and the Pathobiology Graduate Training Program, Johns Hopkins University School of Medicine, 558 Ross Building, 720 Rutland Avenue, Baltimore, MD 21205-2196, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS34100</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000083162">Mitochondrial Permeability Transition Pore</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000064" MajorTopicYN="N">Acclimatization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003080" MajorTopicYN="N">Cold Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019610" MajorTopicYN="N">Cytoprotection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="Y">Hypothermia, Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008931" MajorTopicYN="N">Mitochondria, Muscle</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083162" MajorTopicYN="N">Mitochondrial Permeability Transition Pore</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adenine nucleotide translocase</Keyword><Keyword MajorTopicYN="N">cyclophilin D</Keyword><Keyword MajorTopicYN="N">mitochondrial permeability transition pore</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">therapeutic hypothermia</Keyword></KeywordList><CoiStatement>The authors have no competing financial interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33557211</ArticleId><ArticleId IdType="pmc">PMC7913914</ArticleId><ArticleId IdType="doi">10.3390/cells10020320</ArticleId><ArticleId IdType="pii">cells10020320</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D., Mansfield C., Moussy A., Hermine O. ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? Front. Aging Neurosci. 2017;9:68. doi: 10.3389/fnagi.2017.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases. Pharmaceuticals. 2010;3:839&#x2013;915. doi: 10.3390/ph3040839.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph3040839</ArticleId><ArticleId IdType="pmc">PMC3023298</ArticleId><ArticleId IdType="pubmed">21258649</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson T.C., Kochanek P.M. A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis. Ther. Hypothermia Temp. Manag. 2019;9:13&#x2013;47. doi: 10.1089/ther.2019.0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ther.2019.0001</ArticleId><ArticleId IdType="pmc">PMC6434603</ArticleId><ArticleId IdType="pubmed">30802174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C., Desport J.-C., Clavelou P., Guy N., Derumeaux-Burel H., Ferrier A., Couratier P. Hypermetabolism in ALS patients: An early and persistent phenomenon. J. Neurol. 2009;256:1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Liu Z., Chen K., Price A.C., Pan Y., Swaby J.A., Golden W.C. Motor neuron degeneration in ALS mutant su-peroxide dismutase-1 transgenic mice: Mechanisms of mitochondriopathy and cell death. J. Comp. Neurol. 2007;500:2046. doi: 10.1002/cne.21160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.21160</ArticleId><ArticleId IdType="pubmed">17099894</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Gertz B., Pan Y., Price A.C., Molkentin J.D., Chang Q. The mitochondrial permeability transition pore in motor neurons: Involvement in the pathobiology of ALS mice. Exp. Neurol. 2009;218:333&#x2013;346. doi: 10.1016/j.expneurol.2009.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.02.015</ArticleId><ArticleId IdType="pmc">PMC2710399</ArticleId><ArticleId IdType="pubmed">19272377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K., Northington F.J., Martin L.J. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Brain Struct. Funct. 2009;214:219&#x2013;234. doi: 10.1007/s00429-009-0226-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-009-0226-4</ArticleId><ArticleId IdType="pmc">PMC3010349</ArticleId><ArticleId IdType="pubmed">19888600</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M., Hanaford A. Neonatal Brain Injury and Genetic Causes of Adult-Onset Neurodegenerative Disease in Mice Interact With Effects on Acute and Late Outcomes. Front. Neurol. 2019;10 doi: 10.3389/fneur.2019.00635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00635</ArticleId><ArticleId IdType="pmc">PMC6591316</ArticleId><ArticleId IdType="pubmed">31275228</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerc P., Lipnick S., Willett C. A look into the future of ALS research. Drug Discov. Today. 2016;21:939&#x2013;949. doi: 10.1016/j.drudis.2016.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2016.02.002</ArticleId><ArticleId IdType="pubmed">26861067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302. doi: 10.1093/hmg/ddq106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M. Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome. Front. Neurol. 2020;11 doi: 10.3389/fneur.2020.592851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.592851</ArticleId><ArticleId IdType="pmc">PMC7767933</ArticleId><ArticleId IdType="pubmed">33381076</ArticleId></ArticleIdList></Reference><Reference><Citation>Comerford P.T., Fitzgerald M.J.T. Motor innervation of rodent diaphragm. J. Anat. 1986;149:171&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1261642</ArticleId><ArticleId IdType="pubmed">3693104</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Liu Z. Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron de-generation, improve motor function, and extend survival in amyotrophic lateral sclerosis mice. J. Neuropathol. Exp. Neurol. 2007;66:1002&#x2013;1018. doi: 10.1097/nen.0b013e318158822b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e318158822b</ArticleId><ArticleId IdType="pubmed">17984682</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. An Approach to Experimental Synaptic Pathology Using Green Fluorescent Protein-Transgenic Mice and Gene Knockout Mice to Show Mitochondrial Permeability Transition Pore-Driven Excitotoxicity in Interneurons and Motoneurons. Toxicol. Pathol. 2010;39:220&#x2013;233. doi: 10.1177/0192623310389475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0192623310389475</ArticleId><ArticleId IdType="pmc">PMC3517994</ArticleId><ArticleId IdType="pubmed">21378209</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. p53 is Abnormally Elevated and Active in the CNS of Patients with Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2000;7:613&#x2013;622. doi: 10.1006/nbdi.2000.0314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0314</ArticleId><ArticleId IdType="pubmed">11114260</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Price A.C., McClendon K.B., Al-Abdulla N.A., Subramaniam J.R., Wong P.C., Liu Z. Early events of target deprivation/axotomy-induced neuronal apoptosis in vivo: Oxidative stress, DNA damage, p53 phosphorylation and subcellular redistribution of death proteins. J. Neurochem. 2003;85:234&#x2013;247. doi: 10.1046/j.1471-4159.2003.01659.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01659.x</ArticleId><ArticleId IdType="pubmed">12641745</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter G.A., Jr., Beutner G., Cyclophilin D. somehow a master regulator to mitochondrial function. Biomolecules. 2018;8:176. doi: 10.3390/biom8040176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom8040176</ArticleId><ArticleId IdType="pmc">PMC6316178</ArticleId><ArticleId IdType="pubmed">30558250</ArticleId></ArticleIdList></Reference><Reference><Citation>Baines C.P. The molecular composition of the mitochondrial permeability transition pore. J. Mol. Cell. Cardiol. 2009;46:850&#x2013;857. doi: 10.1016/j.yjmcc.2009.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2009.02.007</ArticleId><ArticleId IdType="pmc">PMC2683186</ArticleId><ArticleId IdType="pubmed">19233198</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankaran S., Laptook A.R., Ehrenkranz R.A., Tyson J.E., McDonald S.A., Donovan E.F., Fanaroff A.A., Poole W.K., Wright L.L., Higgins R.D., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 2005;353:1574&#x2013;1584. doi: 10.1056/NEJMcps050929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcps050929</ArticleId><ArticleId IdType="pubmed">16221780</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankaran S., Pappas A., McDonald S.A., Vohr B.R., Hintz S.R., Yolton K., Gustafson K.E., Leach T.M., Green C., Bara R., et al. Childhood Outcomes after Hypothermia for Neonatal Encephalopathy. New Engl. J. Med. 2012;366:2085&#x2013;2092. doi: 10.1056/NEJMoa1112066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1112066</ArticleId><ArticleId IdType="pmc">PMC3459579</ArticleId><ArticleId IdType="pubmed">22646631</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzopardi D., Strohm B., Marlow N., Brocklehurst P., Deierl A., Eddama O., Goodwin J., Halliday H.L., Juszczak E., Kapellou O., et al. Effects of Hypothermia for Perinatal Asphyxia on Childhood Outcomes. New Engl. J. Med. 2014;371:140&#x2013;149. doi: 10.1056/NEJMoa1315788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1315788</ArticleId><ArticleId IdType="pubmed">25006720</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Wang B., Lee J.-H., Armstrong J.S., Kulikowicz E., Bhalala U.S., Martin L.J., Koehler R.C., Yang Z.-J. Additive Neuroprotection of a 20-HETE Inhibitor with Delayed Therapeutic Hypothermia after Hypoxia-Ischemia in Neonatal Piglets. Dev. Neurosci. 2015;37:376&#x2013;389. doi: 10.1159/000369007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369007</ArticleId><ArticleId IdType="pmc">PMC4514546</ArticleId><ArticleId IdType="pubmed">25721266</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendrick S.E., Xue Q.-S., Streit W.J. Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene. J. Neuroinflammation. 2007;4:9. doi: 10.1186/1742-2094-4-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-4-9</ArticleId><ArticleId IdType="pmc">PMC1808448</ArticleId><ArticleId IdType="pubmed">17328801</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Martinex L., de la Torre M., Toivonen J.M., Zaragoza P., Garcia-Redondo A., Calva A.C., Osta R. Circulating cytokines could not be good prognostic biomarkers in a mouse model of amyotrophic lateral sclerosis. Front. Immunol. 2019;10:801. doi: 10.3389/fimmu.2019.00801.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00801</ArticleId><ArticleId IdType="pmc">PMC6473074</ArticleId><ArticleId IdType="pubmed">31031774</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea M.G., Kullberg B.J., Van Der Meer J.W.M. Circulating Cytokines as Mediators of Fever. Clin. Infect. Dis. 2000;31:S178&#x2013;S184. doi: 10.1086/317513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/317513</ArticleId><ArticleId IdType="pubmed">11113021</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M., Coco D.L., Veglianese P., Vallarola A., Giordana M.T., Marcon G., Beghi E., Poloni M., Strong M.J., Iyer A.M., et al. Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNF&#x3b1;. Mediat. Inflamm. 2017;2017:1&#x2013;16. doi: 10.1155/2017/2985051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/2985051</ArticleId><ArticleId IdType="pmc">PMC5610855</ArticleId><ArticleId IdType="pubmed">29081600</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan K., Gao X., Zhu D. The clinical relevance and mechanism of skeletal muscle wasting. Clin. Nutr. 2021;40:27&#x2013;37. doi: 10.1016/j.clnu.2020.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.07.029</ArticleId><ArticleId IdType="pubmed">32788088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuma K., Aoi W., Yamaguchi A. Molecular mechanism of sarcopenia and cachexia: Recent research advances. Pfl&#xfc;gers Archiv &#x2013; Eur. J. Physiol. 2017;469:573&#x2013;591. doi: 10.1007/s00424-016-1933-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-016-1933-3</ArticleId><ArticleId IdType="pubmed">28101649</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Bonconpagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., et al. Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Petersen A., Wedt P. Thermoregulation in amyotrophic lateral sclerosis. In: Romanovsky A.A., editor. Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II. Volume 157. Elsevier; Amsterdam, The Netherlands: 2018. pp. 749&#x2013;760.</Citation></Reference><Reference><Citation>Dupuis L., Oudart H., Ren&#xe9; F., Gonzalez de Aguilar J.L., Loeffler J.P. Evidence for defective energy homeostasis in amyo-trophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolano M., Provitera V., Manganelli F., Iodice R., Caporaso G., Stancanelli A., Marinou K., Lanzillo B., Santoro L., Mora G. Non-motor involvement in amyotrophic lateral sclerosis: New insight from nerve and vessel analysis in skin biopsy. Neuropathol. Appl. Neurobiol. 2017;43:119&#x2013;132. doi: 10.1111/nan.12332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12332</ArticleId><ArticleId IdType="pubmed">27288647</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis J., Katona I., M&#xfc;ller-Newen G., Sommer C., Necula G., Hendrich C., Ludolph A.C., Sperfeld A.-D. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76:2024&#x2013;2029. doi: 10.1212/WNL.0b013e31821e553a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821e553a</ArticleId><ArticleId IdType="pubmed">21646630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella E.D., Lombardi R., Porretta-Serapiglia C., Ciano C., Gellera C., Pensato V., Cazzato D., Lauria G. Amyotrophic lateral sclerosis causes small fiber pathology. Eur. J. Neurol. 2016;23:416&#x2013;420. doi: 10.1111/ene.12936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12936</ArticleId><ArticleId IdType="pubmed">26806218</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M., Vercruysse P., M&#xfc;ller H.-P., Huppertz H.-J., Rosenbohm A., Nagel G., Weydt P., Peters&#xe9;n &#xc5;., Ludolph A.C., Kassubek J., et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88:1033&#x2013;1041. doi: 10.1136/jnnp-2017-315795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Gampert L., Nething K., Steinacker J.M. Response and function of skeletal muscle heat shock protein 70. Front. Biosci. 2006;11:2802&#x2013;2827. doi: 10.2741/2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2011</ArticleId><ArticleId IdType="pubmed">16720354</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifondorwa D.J., Robinson M.B., Hayes C.D., Taylor A., Prevette D.M., Oppenheim R.W., Caress J., Milligan C.E. Exogenous Delivery of Heat Shock Protein 70 Increases Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis. J. Neurosci. 2007;27:13173&#x2013;13180. doi: 10.1523/JNEUROSCI.4057-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4057-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673412</ArticleId><ArticleId IdType="pubmed">18045911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Ma Q., Yang W., Mackensen G.B., Paschen W. Moderate hypothermia induces marked increase in levels and nuclear accumulation of SUMO2/3-conjugated proteins in neurons. J. Neurochem. 2012;123:349&#x2013;359. doi: 10.1111/j.1471-4159.2012.07916.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07916.x</ArticleId><ArticleId IdType="pmc">PMC3466336</ArticleId><ArticleId IdType="pubmed">22891650</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalal D., Chalissery J., Hassan A.H. Genome maintenance in Saccharomyces cerevisiae: The role of SUMO and SUMO-targeted ubiquitin ligases. Nucleic Acid Res. 2017;45:2242&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389695</ArticleId><ArticleId IdType="pubmed">28115630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann D.M.A., Yates P.O. Motor neurone disease: The nature of the pathogenic mechanism. J. Neurol. Neurosurg. Psychiatry. 1974;37:1036&#x2013;1046. doi: 10.1136/jnnp.37.9.1036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.37.9.1036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W.G., Krasin F. A New Hypothesis of the Etiology of Amyotrophic Lateral Sclerosis. Arch. Neurol. 1982;39:677&#x2013;680. doi: 10.1001/archneur.1982.00510230003001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1982.00510230003001</ArticleId><ArticleId IdType="pubmed">6181766</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzmaurice P.S., Shaw I.C., E Kleiner H., Miller R.T., Monks T.J., Lau S.S., Mitchell J.D., Lynch P.G. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve. 1996;19:797&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">8609941</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. DNA damage and repair: Relevance to mechanisms of neurodegeneration. J. Neuropathol. Exp. Neurol. 2008;67:377&#x2013;387. doi: 10.1097/NEN.0b013e31816ff780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31816ff780</ArticleId><ArticleId IdType="pmc">PMC2474726</ArticleId><ArticleId IdType="pubmed">18431258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B.W., Jeong Y.E., Wong M., Martin L.J. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations. Acta Neuropathol. Commun. 2020;8:1&#x2013;26. doi: 10.1186/s40478-019-0874-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0874-4</ArticleId><ArticleId IdType="pmc">PMC6995159</ArticleId><ArticleId IdType="pubmed">32005289</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M. Enforced DNA repair enzymes rescue neurons from apoptosis induced by target deprivation and axotomy in mouse models of neurodegeneration. Mech. Ageing Dev. 2017;161:149&#x2013;162. doi: 10.1016/j.mad.2016.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2016.06.011</ArticleId><ArticleId IdType="pmc">PMC5192008</ArticleId><ArticleId IdType="pubmed">27364693</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat V., Gane B.D., Nandhakumar S., Rao R. Effect of therapeutic hypothermia on chromosomal aberration in perinatal asphyxia. J. Pediatr. Neurosci. 2016;11:25&#x2013;28. doi: 10.4103/1817-1745.181269.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1817-1745.181269</ArticleId><ArticleId IdType="pmc">PMC4862284</ArticleId><ArticleId IdType="pubmed">27195029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M. Enhanced Uncoupling of the Mitochondrial Respiratory Chain as a Potential Source for Amyotrophic Lateral Sclerosis. Front. Neurol. 2013;4:86. doi: 10.3389/fneur.2013.00086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2013.00086</ArticleId><ArticleId IdType="pmc">PMC3699730</ArticleId><ArticleId IdType="pubmed">23840192</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal-Puig A.J., Grujic D., Zhang C.-Y., Hagen T., Boss O., Ido Y., Szczepanik A., Wade J., Mootha V., Cortright R., et al. Energy Metabolism in Uncoupling Protein 3 Gene Knockout Mice. J. Biol. Chem. 2000;275:16258&#x2013;16266. doi: 10.1074/jbc.M910179199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M910179199</ArticleId><ArticleId IdType="pubmed">10748196</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousset S., Alves-Guerra M.C., Mozo J., Miroux B., Cassard-Doulcier A.M., Bouillaud F., Ricquier D. The biology of mi-tochondrial uncoupling proteins. Diabetes. 2004;53(Suppl. S1):S130&#x2013;S135. doi: 10.2337/diabetes.53.2007.S130.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.53.2007.S130</ArticleId><ArticleId IdType="pubmed">14749278</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabalina I.G., Hoeks J., Kramarova T.V., Schrauwen P., Cannon B., Nedergaard J. Cold tolerance of UCP1-ablated mice: A skeletal muscle mitochondria switch toward lipid oxidation with marked UCP3 up-regulation not associated with increased basal, fatty acid- or ROS-induced uncoupling or enhanced GDP effects. Biochim. et Biophys. Acta (BBA)&#x2014;Bioenerg. 2010;1797:968&#x2013;980. doi: 10.1016/j.bbabio.2010.02.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2010.02.033</ArticleId><ArticleId IdType="pubmed">20227385</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgio V., Soriano M.E., Basso E., Bisetto E., Lippe G., Forte M.A., Bernardi P. Cyclophilin D in mitochondrial pathobi-ology. Biochim. Biophys. Acta. 2010;1997:1113&#x2013;1118. doi: 10.1016/j.bbabio.2009.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2009.12.006</ArticleId><ArticleId IdType="pmc">PMC2888675</ArticleId><ArticleId IdType="pubmed">20026006</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Fancelli D., Wong M., Niedzwiecki M., Ballarini M., Plyte S., Chang Q. GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014;8:433. doi: 10.3389/fncel.2014.00433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00433</ArticleId><ArticleId IdType="pmc">PMC4271619</ArticleId><ArticleId IdType="pubmed">25565966</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahandiez V., Cour M., Bochaton T., Abrial M., Loufouat J., Gharib A., Varennes A., Ovize M., Argaud L. Fast therapeutic hypothermia prevents post-cardiac arrest syndrome through cyclophilin D-mediated mitochondrial permeability transition inhibition. Basic Res. Cardiol. 2017;112:35. doi: 10.1007/s00395-017-0624-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-017-0624-3</ArticleId><ArticleId IdType="pubmed">28492973</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>